NVSI-06-09

· National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NVSI-06-09, covering 2022-11-10 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell) [Phase 2]

See pricing